Contineum Therapeutics, Inc. (CTNM) Net margin
Contineum Therapeutics, Inc. (CTNM) net profit margin by fiscal year — reported net income divided by reported revenue.
45.4%FY2023
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 45.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice